Why the study?
Does serum TgAb level accurately diagnose recurrence in Tg-negative and TgAb-positive DTC patients after successful ablation?
Population
341 patients with histologically confirmed differentiated thyroid carcinoma who had undergone total or…
Comparison
Serum thyroglobulin antibody level measurement vs Clinical routine diagnostic methods
Design
Cohort
Authors
Loading...
May support TgAb surveillance for recurrence in Tg-negative DTC; hypothesis-generating and requires prospective validation.
Does serum TgAb level accurately diagnose recurrence in Tg-negative and TgAb-positive DTC patients after successful ablation?
Serum TgAb level ≥ 246.695 IU/ml is a highly accurate biomarker for detecting disease recurrence in thyroglobulin-negative, TgAb-positive patients with differentiated thyroid carcinoma after successful ablation.
Qun et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: